Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as therapeutic options in the treatment of renal cancer: A meta-analysis

医学 危险系数 内科学 癌症 荟萃分析 血管紧张素转换酶 科克伦图书馆 肿瘤科 泌尿科 置信区间 药理学 血压
作者
Fereshteh Asgharzadeh,Milad Hashemzehi,Reyhaneh Moradi‐Marjaneh,Seyed Mahdi Hassanian,Gordon A. Ferns,Majid Khazaei,Amir Avan
出处
期刊:Life Sciences [Elsevier BV]
卷期号:242: 117181-117181 被引量:30
标识
DOI:10.1016/j.lfs.2019.117181
摘要

Angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) which have been used in the treatment of cardiovascular diseases, have also been shown to have anti-tumor effects against various cancers that include renal cancer. The aim of current paper was to explore the potential clinical impact of ACEI/ARB inhibitors in renal cancer.We used several databases: EMBASE, PubMed and the Cochrane library, to identify clinical studies that assessed the relationship between ACEIs/ARBs treatment and risk of renal cancer incidence or survival of renal cancer patients. The hazard ratio (HR) with 95% confidence intervals were obtained for assessing the relationship between ACEIs/ARBs and renal cancer mortality.The HR for the relationship between ASIs use and survival of renal cancer indicated that patients with renal cancer being treated with ACEIs/ARBs had a significantly lower mortality than non-user (HR 0.723, 95% CI 0.568-0.921, p = 0.009). The HR for the relationship between ACEIs use and survival of renal cancer indicated that patients with renal cancer that used ACEIs had a higher mortality than non-users (HR 1.352, 95% CI 0.917-1.991, p = 0.128). The HR for the relationship between ARBs use and survival of renal cancer indicated that patients with renal cancer that used ARBs had a decreased of mortality than non-users (HR 0.818, 95% CI 0.691-0.969, p = 0.02).This meta-analysis demonstrated that treatment with ACEIs/ARBs may improve renal cancer survival and reduce the mortality of patients with renal cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
xcgh的应助被YANG采纳,获得10
1秒前
1秒前
1秒前
深情安青的应助被Drcai采纳,获得10
1秒前
香蕉觅云的应助被苑小胖采纳,获得10
2秒前
平安完成签到,获得积分10
2秒前
小泥点子完成签到 ,获得积分10
2秒前
m0405完成签到,获得积分10
2秒前
DDD发布了新的文献求助10
2秒前
2秒前
ally发布了新的文献求助10
2秒前
SMQH完成签到,获得积分10
4秒前
123发布了新的文献求助10
4秒前
4秒前
润华发布了新的文献求助10
5秒前
星辰大海发布了新的文献求助10
5秒前
5秒前
情怀的应助被陈欣怡采纳,获得10
5秒前
5秒前
达不溜人给达不溜人的求助进行了留言
6秒前
睿睿子完成签到 ,获得积分10
7秒前
tiao完成签到,获得积分10
7秒前
清爽的大树完成签到,获得积分10
7秒前
8秒前
10秒前
科研通AI6.3的应助被zhugepengju采纳,获得10
10秒前
11秒前
11秒前
852的应助被又又采纳,获得10
12秒前
ybh完成签到,获得积分10
12秒前
sc完成签到,获得积分10
12秒前
CodeCraft的应助被zz不爱读书采纳,获得10
12秒前
13秒前
13秒前
李爱国的应助被我抑郁采纳,获得10
13秒前
13秒前
14秒前
zxcv1完成签到,获得积分10
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187612
求助须知:如何正确求助?哪些是违规求助? 9575734
关于积分的说明 21842594
捐赠科研通 7785476
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559478
邀请新用户注册赠送积分活动 2481952